The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Anti-inflammatory activities of resveratrol in the brain: Role of resveratrol in microglial activation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707 · cited 1×
“Sirt1, one of the silent information regulator 2 (Sir2)-related enzymes, widely exits in the brain, fat, kidney, muscle and liver (Milne et al., 2007).”
BackgroundLiu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 877
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01633.1998 · Cited by 713
Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K., & Ichijo, H. (2005) · Nature Immunology · doi:10.1038/ni1200 · Cited by 667
Inflammation and neurodegeneration in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.005 · Cited by 625
Resveratrol protects against global cerebral ischemic injury in gerbils
Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, A., Lubahn, D., Sun, G. Y., & Sun, A. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03543-6 · Cited by 527
Saiko, P., Szakmary, A., Jaeger, W., & Szekeres, T. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.08.004 · Cited by 442
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Chen, C.-Y., Jang, J.-H., Li, M.-H., & Surh, Y.-J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.237 · Cited by 428
Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ
Pawate, S., Shen, Q., Fan, F., & Bhat, N. R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20180 · Cited by 428
Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration
LIU, B., GAO, H., WANG, J., JEOHN, G., COOPER, C. L., & HONG, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04077.x · Cited by 425
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Jin, F., Wu, Q., Lu, Y.-F., Gong, Q.-H., & Shi, J.-S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384
Self-citationAnti-Inflammatory Responses of Resveratrol
Das, S., & Das, D. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807781696464 · Cited by 382
Della-Morte, D., Dave, K. R., DeFazio, R. A., Bao, Y. C., Raval, A. P., & Perez-Pinzon, M. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.017 · Cited by 375
Bureau, G., Longpré, F., & Martinoli, M. ‐. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21503 · Cited by 334
Novel anti-inflammatory therapy for Parkinson's disease
Gao, H.-M., Liu, B., Zhang, W., & Hong, J.-S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00176-7 · Cited by 324
Lorenz, P., Roychowdhury, S., Engelmann, M., Wolf, G., & Horn, T. F. W. (2003) · Nitric Oxide · doi:10.1016/j.niox.2003.09.005 · Cited by 297
Han, Y., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 297
Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia
Bi, X. L., Yang, J. Y., Dong, Y. X., Wang, J. M., Cui, Y. H., Ikeshima, T., Zhao, Y. Q., & Wu, C. F. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2004.08.008 · Cited by 274
Candelario-Jalil, E., de Oliveira, A. C. P., Gräf, S., Bhatia, H. S., Hüll, M., Muñoz, E., & Fiebich, B. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-25 · Cited by 223
Neuroprotection by resveratrol against traumatic brain injury in rats
Ates, O., Cayli, S., Altinoz, E., Gurses, I., Yucel, N., Sener, M., Kocak, A., & Yologlu, S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9253-0 · Cited by 219
Reactive oxygen species in phagocytic leukocytes
Robinson, J. M. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0461-4 · Cited by 216
Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults
Okawara, M., Katsuki, H., Kurimoto, E., Shibata, H., Kume, T., & Akaike, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.003 · Cited by 200
Resveratrol in prevention and treatment of common clinical conditions of aging.
Markus, M. A., & Morris, B. J. (2008) · PubMed Central · Cited by 196
Resveratrol-loaded polymeric micelles protect cells from Aβ-induced oxidative stress
Lu, X., Ji, C., Xu, H., Li, X., Ding, H., Ye, M., Zhu, Z., Ding, D., Jiang, X., Ding, X., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.021 · Cited by 190
Zhang, F., Shi, J.-S., Zhou, H., Wilson, B., Hong, J.-S., & Gao, H.-M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064535 · Cited by 190
Self-citationPotential Mechanism by Which Resveratrol, a Red Wine Constituent, Protects Neurons
ZHUANG, H., KIM, Y., KOEHLER, R. C., & DORÉ, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07534.x · Cited by 186
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity
Chao, J., Yu, M.-S., Ho, Y.-S., Wang, M., & Chang, R. C.-C. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.07.002 · Cited by 185
Bournival, J., Quessy, P., & Martinoli, M.-G. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9411-5 · Cited by 182
Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice
Blanchet, J., Longpré, F., Bureau, G., Morissette, M., DiPaolo, T., Bronchti, G., & Martinoli, M.-G. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.024 · Cited by 177
Kumar, P., Padi, S. S., Naidu, P. S., & Kumar, A. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00014 · Cited by 167
Ramanan, S., Kooshki, M., Zhao, W., Hsu, F.-C., & Robbins, M. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.002 · Cited by 159
Protective Effect of Resveratrol against Kainate-induced Temporal Lobe Epilepsy in Rats
Wu, Z., Xu, Q., Zhang, L., Kong, D., Ma, R., & Wang, L. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9920-0 · Cited by 152
Kumar, A., Naidu, P. S., Seghal, N., & Padi, S. S. V. (2006) · Pharmacology · doi:10.1159/000097511 · Cited by 147
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia–reperfusion in mice
Gao, D., Zhang, X., Jiang, X., Peng, Y., Huang, W., Cheng, G. S., & Song, L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.030 · Cited by 129
Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury
Kızıltepe, U., Turan, N. N. D., Han, Ü., Ulus, A. T., & Akar, F. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.03.032 · Cited by 121
Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine
Lee, M. K., Kang, S. J., Poncz, M., Song, K., & Park, K. S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.42 · Cited by 100
Meng, X., Yang, J., Chen, G., Wang, L., Zhang, L., Wang, S., Li, J., & Wu, C. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.015 · Cited by 87
Degeneration of neuronal cells due to oxidative stress—microglial contribution
Koutsilieri, E., Scheller, C., Tribl, F., & Riederer, P. F. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00021-4 · Cited by 86
Zamin, L. L., Dillenburg-Pilla, P., Comiran, R. A., Horn, A. P., Simão, F., Nassif, M., Gerhardt, D., Frozza, R. L., & Salbego, C. G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.002 · Cited by 84
Kim, Y. A., Kim, G., Park, K.-Y., & Choi, Y. H. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.143 · Cited by 70
Ban, J. Y., Cho, S. O., Choi, S. H., CHA, H. J., Kim, J. Y., Bae, K., Song, K., & Seong, Y. H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071206 · Cited by 63
Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Nimmo, A. J., & Vink, R. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909788452997 · Cited by 58
Xu, X., & Malavé, A. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00902-4 · Cited by 43
Gong, Q., Wang, Q., Shi, J., Xie-nan, H., Liu, Q., & Ma, H. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00666.x · Cited by 39
Self-citation
Cited by
Resveratrol: A Double-Edged Sword in Health Benefits
Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N., & Sharifi-Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,129
Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases
Forni, C., Facchiano, F., Bartoli, M., Pieretti, S., Facchiano, A., D’Arcangelo, D., Norelli, S., Valle, G., Nisini, R., Beninati, S., et al. (2019) · BioMed Research International · doi:10.1155/2019/8748253 · Cited by 513
Capiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al‐Abed, Y., Davies, P., & Marambaud, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07594.x · Cited by 426
Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403
Neuroprotective action of resveratrol
Bastianetto, S., Ménard, C., & Quirion, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.011 · Cited by 407
Metadata
- Authors
- Zhang, F., Liu, J., & Shi, J.-S.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 636
- Issue
- 1-3
- Pages
- 1-7
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2018101427
- Cited by
- 264
- References
- 52
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.